EMA Approves Two Hybrid Medicines EMA Approves Two Hybrid Medicines
Medications to treat malignant hyperthermia and pediatric hypotension have been recommended for marketing authorization by the European Medicines Agency.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Pharmacist Source Type: news
More News: Cancer & Oncology | European Medicines Agency (EMA) | Intensive Care | Marketing | Pediatrics